Drug
Tislelizumab Combined With Chemoradiotherapy
Tislelizumab Combined With Chemoradiotherapy: highest development phase Phase 2, developed by BeiGene. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- BeiGene
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tislelizumab combined with chemoradiotherapy NCT05547828 | Phase 2 | ESCC |
Latest
No recent events.
Follow Tislelizumab Combined With Chemoradiotherapy on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.